The Day In Review: Biomira Inc. (BIOM) Buys ProlX Pharmaceuticals Corp. For $25.5 Million
10/31/2006 4:45:00 PM
More...
|
PROLX Pharmaceuticals Acquires Worldwide Development And Commercialization Rights For Novel Phosphatidylinositol-3-Kinase Inhibitors
10/19/2005 5:10:51 PM
More...
|
PROLX Pharmaceuticals Reports On Novel Anticancer Drug, PX-866 At International Cancer Meeting And Collaborates For Its Development With The National Cancer Institute
10/19/2005 5:08:43 PM
More...
|